Antimicrobial Agents and Chemotherapy · 1977 · 15 citations · 20 references
Life SciencesInfectious DiseasesPharmacologyAntimicrobial PharmacotherapyAntimicrobial ResistanceMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntimicrobial DosingDrug Interactions With AntimicrobialsUrinary Tract Infection PharmacotherapyUrinary Tract InfectionsAntimicrobial Resistance In Urinary Tract InfectionsDrug Resistance PatternsDrug-drug Interaction EvaluationEscherichia ColiEscherichia Coli Infection TreatmentTreatment Of Bacterial ResistanceUncomplicated Urinary Tract Infection ManagementUrinary Tract Infection Antibiotic Therapy
Cultures of Escherichia coli were exposed to nalidixic acid in an in vitro model in which the conditions of drug-organism interaction resembled those of bacterial cystitis treatment. Results obtained in this way suggested that emergence of bacterial resistance should not be a major problem in treatment of uncomplicated urinary infection; such cases might indeed respond to a less intensive course of treatment than is usual. More prolonged, high-dosage therapy with nalidixic acid may be required for patients with more complicated infections if the risk of failure from the emergence of bacterial resistance is to be minimized.
20
Nalidixic Acid in Infections of Urinary Tract
Andy Barlow · BMJ · 1963 · 73 citations · Full text
Resistance to nalidixic acid. A misconception due to underdosage.
Thomas A. Stamey · PubMed · 1976 · 67 citations
RELATION BETWEEN RESIDUAL URINE VOLUME AND RESPONSE TO TREATMENT OF URINARY INFECTION
David G. Shand, F. O’Grady, C.C. Nimmon et al. · The Lancet · 1970 · 39 citations
Medicine, Nephrology, Urology +8